Abant Izzet Baysal University   Report issue

Academic/Hospital Phase 4
Founded: Bolu Turkey (1992)

Organization Overview

First Clinical Trial
2007
NCT00433823
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Abant Izzet Baysal | Abant Izzet Baysal University | Abant Izzet Baysal University, Bolu Izzet Baysal School of Medicine | Abant İzzet Baysal University Medical Faculty | Abant Izzet Baysal University Medical School, Bolu, TURKEY | anesthesiology and reanimation doctor | Bolu Abant Izzet Baylsa University | Bolu Abant Izzet Baysal University | Bolu Abant Izzet Baysal University Faculty of Health Science | Bolu Abant Izzet Baysal University, Health Sciences Faculty | Bolu Abant Izzet Baysal University, Health Sciences Faculty, Department of Nursing

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Heart Diseases (Phase 4)

Hypercholesterolemia (Phase 4)

Myocardial Ischemia (Phase 4)

Pain, Postoperative (Phase 4)

Tooth, Impacted (Phase 4)

Trismus (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 9